US XPRESS ENTERPRISES INC -A (USX) Fundamental Analysis & Valuation

NYSE:USX • US90338N2027

6.14 USD
0 (0%)
At close: Jun 30, 2023
6.14 USD
0 (0%)
After Hours: 6/30/2023, 8:04:00 PM
Overview Stock Chart Technical Analysis Fundamental Analysis Forecast Earnings Financials Ownership News

This USX fundamental analysis includes valuation metrics, fair value assessment, financial health analysis, profitability trends, growth metrics and dividend sustainability analysis.

Fundamental Rating

1

USX gets a fundamental rating of 1 out of 10. The analysis compared the fundamentals against 42 industry peers in the Ground Transportation industry. USX has a bad profitability rating. Also its financial health evaluation is rather negative. USX does not seem to be growing, but still is valued expensively.


Dividend Valuation Growth Profitability Health

1

1. USX Profitability Analysis

1.1 Basic Checks

  • In the past year USX has reported negative net income.
  • USX had a positive operating cash flow in the past year.
USX Yearly Net Income VS EBIT VS OCF VS FCFUSX Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2016 2017 2018 2019 2020 2021 2022 0 100M -100M

1.2 Ratios

  • USX has negative profitability rations, so we won't be analyzing them here.
Industry RankSector Rank
ROA N/A
ROE N/A
ROIC N/A
ROA(3y)N/A
ROA(5y)N/A
ROE(3y)N/A
ROE(5y)N/A
ROIC(3y)N/A
ROIC(5y)N/A
USX Yearly ROA, ROE, ROICUSX Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2016 2017 2018 2019 2020 2021 2022 0 20 40

1.3 Margins

  • USX has a better Gross Margin (61.79%) than 72.50% of its industry peers.
  • USX's Gross Margin has declined in the last couple of years.
  • USX does not have Profit Margin and Operating Margin available, so we won't be analyzing them here.
Industry RankSector Rank
OM N/A
PM (TTM) N/A
GM 61.79%
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y-0.29%
GM growth 5Y-1.85%
USX Yearly Profit, Operating, Gross MarginsUSX Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2016 2017 2018 2019 2020 2021 2022 0 20 40 60

More info and screens

ROAROEROICOperating and Profit MarginShow most profitable peers

0

2. USX Health Analysis

2.1 Basic Checks

  • USX does not have a ROIC to compare to the WACC, probably because it is not profitable.
  • USX has more shares outstanding than it did 1 year ago.
  • Compared to 1 year ago, USX has a worse debt to assets ratio.
USX Yearly Shares OutstandingUSX Yearly Shares OutstandingYearly Shares Outstanding 2016 2017 2018 2019 2020 2021 2022 10M 20M 30M 40M 50M
USX Yearly Total Debt VS Total AssetsUSX Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2016 2017 2018 2019 2020 2021 2022 200M 400M 600M 800M 1B

2.2 Solvency

  • USX has an Altman-Z score of 1.44. This is a bad value and indicates that USX is not financially healthy and even has some risk of bankruptcy.
  • USX has a worse Altman-Z score (1.44) than 72.50% of its industry peers.
  • A Debt/Equity ratio of 1.79 is on the high side and indicates that USX has dependencies on debt financing.
  • The Debt to Equity ratio of USX (1.79) is worse than 67.50% of its industry peers.
Industry RankSector Rank
Debt/Equity 1.79
Debt/FCF N/A
Altman-Z 1.44
ROIC/WACCN/A
WACC8.23%
USX Yearly LT Debt VS Equity VS FCFUSX Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2016 2017 2018 2019 2020 2021 2022 0 200M 400M

2.3 Liquidity

  • A Current Ratio of 0.71 indicates that USX may have some problems paying its short term obligations.
  • USX has a worse Current ratio (0.71) than 77.50% of its industry peers.
  • A Quick Ratio of 0.69 indicates that USX may have some problems paying its short term obligations.
  • USX has a worse Quick ratio (0.69) than 72.50% of its industry peers.
Industry RankSector Rank
Current Ratio 0.71
Quick Ratio 0.69
USX Yearly Current Assets VS Current LiabilitesUSX Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2016 2017 2018 2019 2020 2021 2022 100M 200M 300M 400M

More info and screens

WACCDebt/EquityHow to determine the health of a companyAltman-Z scoreShow peers with great health

3

3. USX Growth Analysis

3.1 Past

  • USX shows a strong negative growth in Earnings Per Share. In the last year the EPS decreased by -1220.00%.
  • The Revenue has been growing slightly by 6.04% in the past year.
  • Measured over the past years, USX shows a small growth in Revenue. The Revenue has been growing by 6.80% on average per year.
EPS 1Y (TTM)-1220%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%-2450%
Revenue 1Y (TTM)6.04%
Revenue growth 3Y8.17%
Revenue growth 5Y6.8%
Sales Q2Q%-4.73%

3.2 Future

  • Based on estimates for the next years, USX will show a very strong growth in Earnings Per Share. The EPS will grow by 47.15% on average per year.
  • Based on estimates for the next years, USX will show a small growth in Revenue. The Revenue will grow by 3.65% on average per year.
EPS Next Y11.56%
EPS Next 2Y47.89%
EPS Next 3Y47.15%
EPS Next 5YN/A
Revenue Next Year-2.35%
Revenue Next 2Y1.33%
Revenue Next 3Y3.65%
Revenue Next 5YN/A

3.3 Evolution

  • The Revenue growth rate is decreasing: in the next years the growth will be less than in the last years.
USX Yearly Revenue VS EstimatesUSX Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 500M 1B 1.5B 2B
USX Yearly EPS VS EstimatesUSX Yearly EPS VS EstimatesYearly EPS VS Estimates 2018 2019 2020 2021 2022 2023 2024 2025 0 0.5 -0.5 1

More info and screens

Find the best growth stocksShow best growing peers

1

4. USX Valuation Analysis

4.1 Price/Earnings Ratio

  • USX reported negative earnings for the last year, which makes the Price/Earnings Ratio negative.
  • The Price/Forward Earnings ratio is 52.11, which means the current valuation is very expensive for USX.
  • Compared to the rest of the industry, the Price/Forward Earnings ratio of USX indicates a slightly more expensive valuation: USX is more expensive than 67.50% of the companies listed in the same industry.
  • USX's Price/Forward Earnings ratio indicates a rather expensive valuation when compared to the S&P500 average which is at 24.60.
Industry RankSector Rank
PE N/A
Fwd PE 52.11
USX Price Earnings VS Forward Price EarningsUSX Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 0 50 100

4.2 Price Multiples

  • 72.50% of the companies in the same industry are cheaper than USX, based on the Enterprise Value to EBITDA ratio.
Industry RankSector Rank
P/FCF N/A
EV/EBITDA 26.23
USX Per share dataUSX EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 0 10 20 30

4.3 Compensation for Growth

  • The high PEG Ratio(NY), which compensates the Price/Earnings for growth, indicates an expensive valuation of the company.
  • A more expensive valuation may be justified as USX's earnings are expected to grow with 47.15% in the coming years.
PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2Y47.89%
EPS Next 3Y47.15%

More info and screens

Price/EarningsPrice/FCFFCF per shareEV/EBITDAPEG RATIOShow best valued peers

0

5. USX Dividend Analysis

5.1 Amount

  • USX does not give a dividend.
Industry RankSector Rank
Dividend Yield N/A

More info and screens

Find the best dividend stocksShow peers with best dividend

USX Fundamentals: All Metrics, Ratios and Statistics

US XPRESS ENTERPRISES INC -A

NYSE:USX (6/30/2023, 8:04:00 PM)

After market: 6.14 0 (0%)

6.14

0 (0%)

Chartmill FA Rating
GICS SectorIndustrials
GICS IndustryGroupTransportation
GICS IndustryGround Transportation
Earnings (Last)05-10
Earnings (Next)08-01
Inst Owners2.55%
Inst Owner Change-93.88%
Ins Owners2.58%
Ins Owner Change0%
Market Cap331.91M
Revenue(TTM)2.14B
Net Income(TTM)-62.21M
Analysts50
Price Target4.74 (-22.8%)
Short Float %N/A
Short RatioN/A
Dividend
Industry RankSector Rank
Dividend Yield N/A
Yearly DividendN/A
Dividend Growth(5Y)N/A
DPN/A
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)0
Avg EPS beat(2)-67.83%
Min EPS beat(2)-100.64%
Max EPS beat(2)-35.01%
EPS beat(4)0
Avg EPS beat(4)-169.34%
Min EPS beat(4)-334.1%
Max EPS beat(4)-35.01%
EPS beat(8)N/A
Avg EPS beat(8)N/A
EPS beat(12)N/A
Avg EPS beat(12)N/A
EPS beat(16)N/A
Avg EPS beat(16)N/A
Revenue beat(2)1
Avg Revenue beat(2)-1.1%
Min Revenue beat(2)-3.07%
Max Revenue beat(2)0.88%
Revenue beat(4)2
Avg Revenue beat(4)-0.64%
Min Revenue beat(4)-3.07%
Max Revenue beat(4)0.88%
Revenue beat(8)N/A
Avg Revenue beat(8)N/A
Revenue beat(12)N/A
Avg Revenue beat(12)N/A
Revenue beat(16)N/A
Avg Revenue beat(16)N/A
PT rev (1m)0%
PT rev (3m)40.2%
EPS NQ rev (1m)0%
EPS NQ rev (3m)-13.33%
EPS NY rev (1m)0%
EPS NY rev (3m)-6.77%
Revenue NQ rev (1m)0%
Revenue NQ rev (3m)-0.47%
Revenue NY rev (1m)0%
Revenue NY rev (3m)-0.66%
Valuation
Industry RankSector Rank
PE N/A
Fwd PE 52.11
P/S 0.16
P/FCF N/A
P/OCF 7.25
P/B 1.56
P/tB 2.55
EV/EBITDA 26.23
EPS(TTM)-1.12
EYN/A
EPS(NY)0.12
Fwd EY1.92%
FCF(TTM)-2.78
FCFYN/A
OCF(TTM)0.85
OCFY13.8%
SpS39.53
BVpS3.94
TBVpS2.41
PEG (NY)N/A
PEG (5Y)N/A
Graham NumberN/A
Profitability
Industry RankSector Rank
ROA N/A
ROE N/A
ROCE N/A
ROIC N/A
ROICexc N/A
ROICexgc N/A
OM N/A
PM (TTM) N/A
GM 61.79%
FCFM N/A
ROA(3y)N/A
ROA(5y)N/A
ROE(3y)N/A
ROE(5y)N/A
ROIC(3y)N/A
ROIC(5y)N/A
ROICexc(3y)N/A
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)N/A
ROCE(5y)N/A
ROICexgc growth 3YN/A
ROICexgc growth 5YN/A
ROICexc growth 3YN/A
ROICexc growth 5YN/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y-0.29%
GM growth 5Y-1.85%
F-Score4
Asset Turnover1.58
Health
Industry RankSector Rank
Debt/Equity 1.79
Debt/FCF N/A
Debt/EBITDA 16.14
Cap/Depr 222.01%
Cap/Sales N/A
Interest Coverage N/A
Cash Conversion N/A
Profit Quality N/A
Current Ratio 0.71
Quick Ratio 0.69
Altman-Z 1.44
F-Score4
WACC8.23%
ROIC/WACCN/A
Cap/Depr(3y)226.34%
Cap/Depr(5y)218.67%
Cap/Sales(3y)N/A
Cap/Sales(5y)N/A
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)-1220%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%-2450%
EPS Next Y11.56%
EPS Next 2Y47.89%
EPS Next 3Y47.15%
EPS Next 5YN/A
Revenue 1Y (TTM)6.04%
Revenue growth 3Y8.17%
Revenue growth 5Y6.8%
Sales Q2Q%-4.73%
Revenue Next Year-2.35%
Revenue Next 2Y1.33%
Revenue Next 3Y3.65%
Revenue Next 5YN/A
EBIT growth 1Y-652.72%
EBIT growth 3YN/A
EBIT growth 5YN/A
EBIT Next Year611.66%
EBIT Next 3Y131.85%
EBIT Next 5YN/A
FCF growth 1Y-1114.43%
FCF growth 3YN/A
FCF growth 5YN/A
OCF growth 1Y-68.64%
OCF growth 3Y-27.8%
OCF growth 5Y-12.64%

US XPRESS ENTERPRISES INC -A / USX FAQ

What is the ChartMill fundamental rating of US XPRESS ENTERPRISES INC -A (USX) stock?

ChartMill assigns a fundamental rating of 2 / 10 to USX.


What is the valuation status for USX stock?

ChartMill assigns a valuation rating of 1 / 10 to US XPRESS ENTERPRISES INC -A (USX). This can be considered as Overvalued.


Can you provide the profitability details for US XPRESS ENTERPRISES INC -A?

US XPRESS ENTERPRISES INC -A (USX) has a profitability rating of 1 / 10.


Can you provide the financial health for USX stock?

The financial health rating of US XPRESS ENTERPRISES INC -A (USX) is 1 / 10.


Can you provide the expected EPS growth for USX stock?

The Earnings per Share (EPS) of US XPRESS ENTERPRISES INC -A (USX) is expected to grow by 11.56% in the next year.